Sort   by:  
 Page size 
UnknownManagement of Marginal Zone Lymphoma: A Canadian Perspective.
Not available
S-EPMC9955247 | biostudies-literature
UnknownCombined modality therapy versus chemotherapy alone as an induction regimen for primary central nervous system lymphoma: a cost-effectiveness analysis.
Not available
S-EPMC4165417 | biostudies-literature
UnknownThe Use of Virtual Care in Patients with Hematologic Malignancies: A Scoping Review.
Not available
S-EPMC8871074 | biostudies-literature
UnknownIbrutinib Plus RCHOP versus RCHOP Only in Young Patients with Activated B-Cell-like Diffuse Large B-Cell Lymphoma (ABC-DLBCL): A Cost-Effectiveness Analysis.
Not available
S-EPMC10742773 | biostudies-literature
UnknownOutcomes and factors influencing survival in patients with diffuse large B-cell lymphoma: a population-based analysis.
Not available
S-EPMC12318267 | biostudies-literature
UnknownEmerging therapies for the treatment of relapsed or refractory follicular lymphoma.
Not available
S-EPMC5176374 | biostudies-literature
UnknownLeadless Pacemakers in Complex Congenital Heart Disease.
Not available
S-EPMC12693286 | biostudies-literature
UnknownOutcomes of Primary Mediastinal B-cell Lymphoma Patients with Partial Metabolic Response: A Multicenter Retrospective Analysis.
Not available
S-EPMC12023749 | biostudies-literature
UnknownHealth care utilization and costs for frail vs nonfrail patients with diffuse large B-cell lymphoma.
Not available
S-EPMC11401182 | biostudies-literature
UnknownValemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study.
Not available
S-EPMC12912197 | biostudies-literature
Sort   by:  
 Page size